Similar articles for PMID: 21383673

Year	Number of Results
1983	1
1984	1
1987	1
1989	1
1992	4
1994	2
1996	3
1997	1
1999	3
2001	2
2002	3
2003	2
2004	4
2005	4
2006	5
2007	4
2008	5
2009	4
2010	7
2011	8
2012	4
2013	6
2014	9
2015	3
2016	4
2017	3
2018	4
2019	1
2020	8
2021	3
2022	2
2023	1
2024	0

1

Arterial pathology in canine mucopolysaccharidosis-I and response to therapy.

Lyons JA, Dickson PI, Wall JS, Passage MB, Ellinwood NM, Kakkis ED, McEntee MF. Lyons JA, et al. Lab Invest. 2011 May;91(5):665-74. doi: 10.1038/labinvest.2011.7. Epub 2011 Mar 7. Lab Invest. 2011. PMID: 21383673 Free PMC article.

2

Ocular lesions in canine mucopolysaccharidosis I and response to enzyme replacement therapy.

Newkirk KM, Atkins RM, Dickson PI, Rohrbach BW, McEntee MF. Newkirk KM, et al. Invest Ophthalmol Vis Sci. 2011 Jul 11;52(8):5130-5. doi: 10.1167/iovs.10-6751. Invest Ophthalmol Vis Sci. 2011. PMID: 21436264

3

Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I.

Dickson P, Peinovich M, McEntee M, Lester T, Le S, Krieger A, Manuel H, Jabagat C, Passage M, Kakkis ED. Dickson P, et al. J Clin Invest. 2008 Aug;118(8):2868-76. doi: 10.1172/JCI34676. J Clin Invest. 2008. PMID: 18654665 Free PMC article.

4

Replacing the enzyme alpha-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I.

Dierenfeld AD, McEntee MF, Vogler CA, Vite CH, Chen AH, Passage M, Le S, Shah S, Jens JK, Snella EM, Kline KL, Parkes JD, Ware WA, Moran LE, Fales-Williams AJ, Wengert JA, Whitley RD, Betts DM, Boal AM, Riedesel EA, Gross W, Ellinwood NM, Dickson PI. Dierenfeld AD, et al. Sci Transl Med. 2010 Dec 1;2(60):60ra89. doi: 10.1126/scitranslmed.3001380. Sci Transl Med. 2010. PMID: 21123810 Free PMC article.

5

Biodistribution and pharmacodynamics of recombinant human alpha-L-iduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrations.

Vite CH, Wang P, Patel RT, Walton RM, Walkley SU, Sellers RS, Ellinwood NM, Cheng AS, White JT, O'Neill CA, Haskins M. Vite CH, et al. Mol Genet Metab. 2011 Jul;103(3):268-74. doi: 10.1016/j.ymgme.2011.03.011. Epub 2011 Mar 21. Mol Genet Metab. 2011. PMID: 21482164 Free PMC article.

6

Specific antibody titer alters the effectiveness of intrathecal enzyme replacement therapy in canine mucopolysaccharidosis I.

Dickson PI, Ellinwood NM, Brown JR, Witt RG, Le SQ, Passage MB, Vera MU, Crawford BE. Dickson PI, et al. Mol Genet Metab. 2012 May;106(1):68-72. doi: 10.1016/j.ymgme.2012.02.003. Epub 2012 Feb 8. Mol Genet Metab. 2012. PMID: 22402327 Free PMC article.

7

Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I.

Kakkis E, McEntee M, Vogler C, Le S, Levy B, Belichenko P, Mobley W, Dickson P, Hanson S, Passage M. Kakkis E, et al. Mol Genet Metab. 2004 Sep-Oct;83(1-2):163-74. doi: 10.1016/j.ymgme.2004.07.003. Mol Genet Metab. 2004. PMID: 15464431

8

Glycosaminoglycan storage in neuroanatomical regions of mucopolysaccharidosis I dogs following intrathecal recombinant human iduronidase.

Chen A, Vogler C, McEntee M, Hanson S, Ellinwood NM, Jens J, Snella E, Passage M, Le S, Guerra C, Dickson P. Chen A, et al. APMIS. 2011 Aug;119(8):513-21. doi: 10.1111/j.1600-0463.2011.02760.x. Epub 2011 May 14. APMIS. 2011. PMID: 21749451 Free PMC article.

9

Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I.

Wang RY, Aminian A, McEntee MF, Kan SH, Simonaro CM, Lamanna WC, Lawrence R, Ellinwood NM, Guerra C, Le SQ, Dickson PI, Esko JD. Wang RY, et al. Mol Genet Metab. 2014 Aug;112(4):286-93. doi: 10.1016/j.ymgme.2014.05.015. Epub 2014 Jun 6. Mol Genet Metab. 2014. PMID: 24951454 Free PMC article.

10

Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vector.

Di Domenico C, Villani GR, Di Napoli D, Reyero EG, Lombardo A, Naldini L, Di Natale P. Di Domenico C, et al. Hum Gene Ther. 2005 Jan;16(1):81-90. doi: 10.1089/hum.2005.16.81. Hum Gene Ther. 2005. PMID: 15703491

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year